Stockreport

Opus Genetics to Present at Upcoming Medical and Industry Conferences in October 2025 [Yahoo! Finance]

Opus Genetics, Inc.  (IRD) 
PDF Genetics, Inc . (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small mole [Read more]